BioCentury
ARTICLE | Financial News

XTL proposes follow-on

January 11, 2016 8:00 AM UTC

XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB; Tel Aviv:XTL), Herzliya, Israel Business: Cancer, Neurology, Infectious Date announced: 2015-12-31 Type: Follow-on To be raised: Up to $17.3 million Shares: T...